Skip to main content

Table 1 Baseline values for cardiac volume and function parameters.

From: Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

  Deferiprone Deferoxamine p
No. Patients randomized 28 32  
Age 25.1 ± 3.8 26.6 ± 4.7 0.33
Male sex (%) 15 (52) 16 (50) 0.99
Weight (kg) 57.7 ± 7.9 60.6 ± 13.2 0.30
Cardiac parameters    
Myocardial T2* (ms) 13.0 (32%) 13.3 (30%) 0.77
LVEDV (mL) 134 ± 32 132 ± 23 0.81
LVESV (mL) 43 ± 14 41 ± 13 0.51
LVEF (%) 69.7 ± 5.4 68.4 ± 4.9 0.34
RVEDV (mL) 122.5 ± 24.9 124.7 ± 27.7 0.75
RVESV (mL) 37.7 ± 11.7 38.1 ± 12.6 0.90
RVEF (%) 69.6 ± 5.2 70.0 ± 5.8 0.79
Biochemical markers    
Liver iron concentration (μg/L) 6.16 ± 6.0 6.32 ± 5.8 0.92
Serum ferritin (μg/L) 1791 ± 1029 2795 ± 2441 0.039
Haematology    
Transfusional iron (mL/kg/year) 152 ± 43.4 144 ± 44.4 0.53
Haemoglobin level (g/L) 105 ± 12.0 113 ± 11.9 0.023
  1. Values are mean ± SD except for T2* where values are geometric mean with CV.